The FDA rejected Moderna's application for its mRNA flu vaccine, citing concerns over the design of its pivotal clinical trial,…
Read More »mRNA-1010
Entity category: technology
Moderna's mRNA flu vaccine showed 27% better protection than traditional flu shots in a phase 3 trial with 41,000 participants,…
Read More »
